Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 194896, 8 pages
http://dx.doi.org/10.1155/2010/194896
Research Article

Rhizoma coptidis Inhibits LPS-Induced MCP-1/CCL2 Production in Murine Macrophages via an AP-1 and NF B-Dependent Pathway

1Medizinische Klinik III, Universität Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
2Deutsche Gesellschaft für Traditionelle Chinesische Medizin (DGTCM), 69126 Heidelberg, Germany
3Institute of Biomedical Sciences Abel Salazar, Porto University, 4099-002 Porto, Portugal
4Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195-7234, USA
5Medizinische Klinik IV, Universität Heidelberg, 69120 Heidlberg, Germany

Received 3 December 2009; Revised 18 April 2010; Accepted 7 May 2010

Academic Editor: Giuseppe Valacchi

Copyright © 2010 Andrew Remppis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Gao, S. Leng, F. Lu, M. Xie, L. Xu, and K. Wang, “Effect of berberine on expression of hepatocyte nuclear factor-4α in rats with fructose-induced insulin resistance,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 28, no. 3, pp. 261–265, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Wang, Y. Huang, K. S. L. Lam et al., “Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase,” Cardiovascular Research, vol. 82, no. 3, pp. 484–492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Yin, H. Zhang, and J. Ye, “Traditional Chinese medicine in treatment of metabolic syndrome,” Endocrine, Metabolic and Immune Disorders: Drug Targets, vol. 8, no. 2, pp. 99–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Zhou, S. Zhou, J. Tang et al., “Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats,” European Journal of Pharmacology, vol. 606, no. 1–3, pp. 262–268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Kong, J. Wei, P. Abidi et al., “Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins,” Nature Medicine, vol. 10, no. 12, pp. 1344–1351, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Enk, R. Ehehalt, J. E. Graham, A. Bierhaus, A. Remppis, and H. J. Greten, “Differential effect of Rhizoma coptidis and its main alkaloid compound berberine on TNF-α induced NFκB translocation in human keratinocytes,” Journal of Ethnopharmacology, vol. 109, no. 1, pp. 170–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-P. Lin, J.-S. Yang, C.-C. Wu et al., “Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro,” In Vivo, vol. 22, no. 2, pp. 223–230, 2008. View at Google Scholar · View at Scopus
  8. Y.-T. Ho, J.-S. Yang, T.-C. Li et al., “Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-κB, u-PA and MMP-2 and -9,” Cancer Letters, vol. 279, no. 2, pp. 155–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kim, J. H. Choi, J. B. Kim et al., “Berberine suppresses TNF-α-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells,” Molecules, vol. 13, no. 12, pp. 2975–2985, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Fukuda, Y. Hibiya, M. Mutoh, M. Koshiji, S. Akao, and H. Fujiwara, “Inhibition of activator protein 1 activity by berberine in human hepatoma cells,” Planta Medica, vol. 65, no. 4, pp. 381–383, 1999. View at Google Scholar · View at Scopus
  11. K.-W. Liang, C.-T. Ting, S.-C. Yin et al., “Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury,” Biochemical Pharmacology, vol. 71, no. 6, pp. 806–817, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. K.-W. Liang, S.-C. Yin, C.-T. Ting et al., “Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells,” European Journal of Pharmacology, vol. 590, no. 1–3, pp. 343–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-Y. Hsiang, S.-L. Wu, S.-E. Cheng, and T.-Y. Ho, “Acetaldehyde-induced interleukin-1β and tumor necrosis factor-α production is inhibited by berberine through nuclear factor-κB signaling pathway in HepG2 cells,” Journal of Biomedical Science, vol. 12, no. 5, pp. 791–801, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-S. Lu, Y.-Q. Liu, M. Li, B.-S. Li, and Y. Xu, “Protective effects and its mechanisms of total alkaloids from rhizoma Coptis chinensis on Helicobacter pylori LPS induced gastric lesion in rats,” Zhongguo Zhongyao Zazhi, vol. 32, no. 13, pp. 1333–1336, 2007. View at Google Scholar · View at Scopus
  15. E.-K. Park, H. I. Rhee, H.-S. Jung et al., “Antiinflammatory effects of a combined herbal preparation (RAH13) of Phellodendron amurense and Coptis chinensis in animal models of inflammation,” Phytotherapy Research, vol. 21, no. 8, pp. 746–750, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Hoppe-Seyler, K. Butz, C. Rittmuller, and M. von Knebel Doeberitz, “A rapid microscale procedure for the simultaneous preparation of cytoplasmic RNA, nuclear DNA binding proteins and enzymatically active luciferase extracts,” Nucleic Acids Research, vol. 19, no. 18, p. 5080, 1991. View at Google Scholar · View at Scopus
  17. J. Liu, C. He, K. Zhou, J. Wang, and J. X. Kang, “Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 378, no. 2, pp. 174–178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Y.-S. Hsieh, W.-H. Kuo, T.-W. Lin et al., “Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells,” Journal of Agricultural and Food Chemistry, vol. 55, no. 25, pp. 10437–10445, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Huang, L. Wang, S. Meng, Y. Wang, T. Chen, and C. Wang, “Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages,” International Journal of Cardiology, July 2. In press. View at Publisher · View at Google Scholar
  20. F. L. Chen, Z. H. Yang, Y. Liu et al., “Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway,” Endocrine, vol. 33, no. 3, pp. 331–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. K.-W. Kim, K.-T. Ha, C.-S. Park et al., “Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages,” Vascular Pharmacology, vol. 47, no. 2-3, pp. 99–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. W. Jeong, K. C. Hsu, J.-W. Lee et al., “Berberine suppresses proinflammatory responses through AMPK activation in macrophages,” American Journal of Physiology, vol. 296, no. 4, pp. E955–E964, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. Z.-Q. Yan and G. K. Hansson, “Innate immunity, macrophage activation, and atherosclerosis,” Immunological Reviews, vol. 219, no. 1, pp. 187–203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. J. Ko, J.-S. Lee, B. C. Park, H. M. Shin, and J.-A. Kim, “Inhibitory effects of Zoagumhwan water extract and berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte adhesion to endothelial cells,” Vascular Pharmacology, vol. 47, no. 2-3, pp. 189–196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. L. Chen, Z. H. Yang, Y. Liu et al., “Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway,” Endocrine, vol. 33, no. 3, pp. 331–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Li, W. Yao, X. Zheng, and K. Liao, “Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor a expression in macrophage,” Cell Research, vol. 19, no. 8, pp. 1006–1017, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Li, B. Dong, S. W. Park, H.-S. Lee, W. Chen, and J. Liu, “Hepatocyte nuclear factor 1α plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine,” Journal of Biological Chemistry, vol. 284, no. 42, pp. 28885–28895, 2009. View at Publisher · View at Google Scholar · View at Scopus